Results 241 to 250 of about 136,379 (287)

[Papillary renal cell carcinoma spectrum].

Actas urologicas espanolas, 2009
Significant conceptual expansion of renal cancer continues to increase. The key point to this phenomenon is based on the combination of morphology and molecular data. The result is the new 2004 WHO classification of renal tumors in adults. The apparently never ending advance in molecular genetics is constantly pushing to update recently proposed ...
A, Ugalde, J I, López
openaire   +1 more source

MUTATION OF THE VHL GENE IS ASSOCIATED EXCLUSIVELY WITH THE DEVELOPMENT OF NON‐PAPILLARY RENAL CELL CARCINOMAS

Journal of Pathology, 1996
C. Kenck, M. Wilhelm, P. Bugert, G. Staehler, G. Kovacs   +4 more
semanticscholar   +1 more source

Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non‐papillary renal cell carcinomas

Journal of Pathology, 1997
D. Schullerus, J. Herbers, J. Chudek, H. Kanamaru, G. Kovacs   +4 more
semanticscholar   +1 more source

Papillary renal cell carcinoma

2023
openaire   +2 more sources

Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene

Oncogene, 2000
L. Glukhova, C. Lavialle, D. Fauvet, I. Chudoba, G. Danglot, E. Angevin, A. Bernheim, A. Goguel   +7 more
semanticscholar   +1 more source

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Balazs Dome
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Role of PSF-TFE3 oncoprotein in the development of papillary renal cell carcinomas

Oncogene, 2007
M. Mathur, H. Samuels
semanticscholar   +1 more source

Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors.

Cancer Research, 2003
B. Gunawan, A. von Heydebreck, T. Fritsch, W. Huber, R. Ringert, G. Jakse, L. Füzesi   +6 more
semanticscholar   +1 more source

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly